Effects of antiplatelet therapy and oral anticoagulation on indices of endothelial damage/dysfunction in patients with systolic heart failure in sinus rhythm

Thrombosis Research

Volumn 116, Issue 2, 2005, Pages 181-183

  Aun, Yeong Chong ^a   Chin, Bernard S P ^a   Blann, Andrew D ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

E selectin; Endothelial damage; Endothelial dysfunction; Heart failure; Von Willebrand factor

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; VON WILLEBRAND FACTOR; WARFARIN;

ANTICOAGULATION; BATCH PROCESS; BLOOD SAMPLING; CENTRIFUGATION; DRUG EFFECT; ECHOCARDIOGRAPHY; ENDOTHELIUM INJURY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; INFORMED CONSENT; LABORATORY TEST; LETTER; PRIORITY JOURNAL; SINUS RHYTHM; SYSTOLIC BLOOD PRESSURE;

AGED; ANTICOAGULANTS; BIOLOGICAL MARKERS; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; TACHYCARDIA, SINUS; THROMBOMODULIN; VON WILLEBRAND FACTOR;

EID: 19344373502     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.11.023     Document Type: Letter

References (15)

1. D.H. Spodick, and D. Littmann Idiopathic myocardial hypertrophy Am. J. Cardiol. 1 5 1958 610 623
2. W.C. Roberts, R.J. Siegel, and B.M. McManus Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients Am. J. Cardiol. 60 16 1987 1340 1355
3. V. Fuster, B.J. Gersh, E.R. Giuliani, A.J. Tajik, R.O. Brandenburg, and R.L. Frye The natural history of idiopathic dilated cardiomyopathy Am. J. Cardiol. 47 3 1981 525 531
4. G.Y. Lip, and C.R. Gibbs Does heart failure confer a hypercoagulable state? Virchow's triad revisited J. Am. Coll. Cardiol. 33 5 1999 1424 1426
5. C.G. Jones, and J.G. Cleland Meeting report-the LIDO, HOPE, MOXCON and WASH studies. Heart outcomes prevention evaluation. The Warfarin/Aspirin study of heart failure Eur. J. Heart Fail. 1 4 1999 425 431
6. J.G. Cleland, J. Ghosh, N. Freemantle, G.C. Kaye, M. Nasir, and A.L. Clark Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure Eur. J. Heart Fail. 6 4 2004 501 508
7. G.Y. Lip, and C.R. Gibbs Anticoagulation for heart failure in sinus rhythm Cochrane Database Syst. Rev. 4 2001 [CD003336]
8. G.Y. Lip, and C.R. Gibbs Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm Cochrane Database Syst. Rev. 4 2001 [CD003333]
9. V. Roldan, F. Marin, A.D. Blann, A. Garcia, P. Marco, and F. Sogorb Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation Eur. Heart J. 24 14 2003 1373 1380
10. G. Kaplanski, M. Fabrigoule, V. Boulay, C.A. Dinarello, P. Bongrand, and S. Kaplanski Thrombin induces endothelial type II activation in vitro: IL-1 and TNF-alpha-independent IL-8 secretion and E-selectin expression J. Immunol. 158 11 1997 5435 5441
11. W.M. Feinberg, E.S. Cornell, S.D. Nightingale, L.A. Pearce, R.P. Tracy, and R.G. Hart Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators Stroke 28 6 1997 1101 1106
12. B. Di Micco, G. Colonna, P. Di Micco, G. Di Micco, B.M. Russo, and M.A. Macalello Anti-thrombin action of low-dose acetylsalicylic acid Eur. J. Pharmacol. 460 1 2003 59 62
13. A. Undas, R. Undas, J. Musial, and A. Szczeklik A low dose of aspirin (75 mg/day) lowers thrombin generation to a similar extent as a high dose of aspirin (300 mg/day) Blood Coagul. Fibrinolysis 11 3 2000 231 234
14. J. Eritsland, I. Seljeflot, H. Arnesen, P. Smith, and A.B. Westvik Effects of long-term treatment with warfarin on fibrinogen, FPA, TAT, and D-dimer in patients with coronary artery disease Thromb. Res. 66 1 1992 55 60
15. V.V. Sullivan, A.E. Hawley, D.M. Farris, B.S. Knipp, A.J. Varga, and S.K. Wrobleski Decrease in fibrin content of venous thrombi in selectin-deficient mice J. Surg. Res. 109 1 2003 1 7